GOLDIC therapy in degenerative lumbar spinal stenosis: randomized, controlled trial

Area of Science:

• Orthopedics
• Neurosurgery
• Regenerative Medicine

Background:

• Degenerative lumbar spinal stenosis (DLSS) is a common condition causing pain and disability.
• Conservative treatments like epidural steroid injections and manual therapy are frequently used.
• Novel therapeutic options are needed to improve outcomes for DLSS patients.

Purpose of the Study:

• To compare the efficacy of epidural GOLDIC serum, epidural steroid injections, and manual therapy for DLSS.
• To evaluate pain intensity, functional disability, and quality of life in patients with DLSS.

Main Methods:

• A randomized controlled trial was conducted with 90 patients divided into three groups (n=30 each).
• Interventions included epidural GOLDIC serum, epidural steroid injections (dexamethasone), or manual therapy.
• Outcomes were assessed at baseline and at 4, 12, and 24 weeks post-intervention using validated questionnaires.

Main Results:

• Epidural GOLDIC serum demonstrated the highest mean differences and the greatest number of patients achieving minimal important difference across all primary outcome measures.
• GOLDIC therapy was not inferior to epidural steroid injections or manual therapy in treating DLSS.

Conclusions:

• Epidural GOLDIC serum represents a promising new nonoperative treatment option for symptomatic DLSS.
• GOLDIC therapy offers comparable or superior outcomes to established conservative treatments for DLSS.